Data as of 4:00pm ET
| +2.46 / +0.95%|
The 17 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 290.00, with a high estimate of 315.00 and a low estimate of 225.00. The median estimate represents a +10.51% increase from the last price of 262.42.
The current consensus among 21 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since May, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.